US Patent Issued to Metro International Biotech on Aug. 19 for "Crystal forms of beta-nicotinamide mononucleotide" (British, Belgian, American Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,721, issued on Aug. 19, was assigned to Metro International Biotech LLC (Worcester, Mass.).

"Crystal forms of beta-nicotinamide mononucleotide" was invented by David J. Livingston (Worcester, Mass.), Andrew Carr (Hinxton, Great Britain) and Philippe Fernandes (Turnhout, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to crystalline forms of a Beta-nicotinamide mononucleotide, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to preparations suitable for nutraceutical, veterinary, and agriculturally-relevant uses."

The patent was filed on Jan. 16, 2025, under Applic...